首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 3期 => 综述 =>肝硬化患者稀释性低钠血症的研究现状与展望
肝硬化患者稀释性低钠血症的研究现状与展望
Research state and prospect of hyponatremia in cirrhosis
文章发布日期:2011年02月12日  来源:  作者:胡玉琳 全香兰  点击次数:4780次  下载次数:868次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:稀释性低钠血症(DH)是肝硬化腹水患者常发生的一个并发症,并与难以控制的腹水、肝性脑病(HE)、自发性细菌性腹膜炎(SBP)及肝肾综合征(HRS)密切相关。肝硬化患者DH,轻者可表现为疲乏无力、肌张力低,重者可出现低钠性脑病,表现为认知、运动功能障碍,严重者可出现抽搐或昏迷。肝移植前存在DH的患者,其移植后的并发症和病死率明显增加。治疗上限制水摄入、输入白蛋白以纠正DH,严重低钠血症,静脉补充高张钠。几种非肽V2受体拮抗剂有望在肝硬化患者DH的治疗上发挥一定的作用。
【Abstract】:Dilutional hyponatremia (DH) is a common complication of patients diagnosed with cirrhosis and is closely related with refractory ascites, hepatic encephalopathy(HE), spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome (HRS). The common symptoms of hepatocirrhotic patients with mild dilutional hyponatremia are fatigue and muscle weakness. The clinical manifestations of severe cases can be encephalopathy characterized by cognitive and motor disturbances, even convulsion or coma. If the patients preparing for liver transplantation have dilutional hyponatremia, the complications and death occur more often after the transplantation. The treatments for dilutional hyponatremia include water restriction and albumin transfusion. Injection of hypertonic saline is necessary for treating severe hyponatremia. Several non-peptide V2 receptor antagonists are likely to play a role in the treatment of dilutional hyponatremia.
【关键字】:肝硬化;低钠血症
【Key words】:liver cirrhosis; hyponatremia
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号